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Abstract 
Background: To analyze the clinicopathological profile of young patients (≤ 40 years) with oral SCC and correlate 
with a control group (≥ 50 years) by means of histopathological grading systems. 
Material and Methods: 14 young patients and 14 control patients were selected with similar clinical stage and 
tumor location. Demographic and clinical data were obtained from patient records and histological sections were 
evaluated according to four histopathological grading systems. Associations between categories of demographic 
and clinical data were performed through Chi-square test and Exact Fisher test. The survival analyzes were per-
formed according to the Kaplan-Meier method. 
Results: The comparison between groups showed a greater association of treatment modalities in younger patients 
(p=0.022), they had a higher incidence of local recurrence and regional metastasis (p=0.018) and lower disease-
free survival in 5 years (p=0.069). There was no difference in 5-year overall survival among the studied groups. 
There was no difference in histological grading between studied groups according to the four used systems. 
Conclusions: This study showed that, despite tumors had similar histological grade and more therapeutic mo-
dalities were used in the young group, tumors in young patients had a higher incidence of recurrence/metastasis, 
showing tendency to a more aggressive behavior. 
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Introduction
Squamous cell carcinoma (SCC) originates in the strati-
fied squamous epithelium and represents 90-95% of all 
malignant neoplasms in the oral cavity (1). This disease 
affects mostly males, after the fifth decade of life and is 
strongly associated with alcohol and tobacco abuse (2). 
The oral SCC is an uncommon disease in patients under 
the age of 40 years old, and its incidence ranges from 
0.4 to 6% of the cases. However, in recent years this 
number has been increasing gradually (3-5). According 
to some authors, young patients with SCC have a distinct 
clinical profile and limited association with traditional 
risk factors (1,3,5,6). Furthermore, it is considered that 
the process of oncogenesis in young adults may be dif-
ferent from that which occurs in elderly patients (7,8). 
According to Santos-Silva et al. (5), the high incidence 
of abnormalities in cellular DNA suggests that young 
patients with oral cancer may have increased genomic 
instability, indicating genetic differences between the 
disease of these patients and the elderly.
In order to standardize information, it was developed 
the “TNM Classification of Malignant Tumors Sys-
tem”, which, today, is still the most used clinical stag-
ing system. However, this system has some limitations, 
especially in relation to previewing prognosis, as some 
patients with early oral SCC evolve badly and others 
with advanced tumors survive (9). It is considered that 
its greatest disadvantage is the inability to follow the 
advances in the understanding of cancer biology and 
incorporate new prognostic variables, as they become 
available (10). 
In order to fill this gap, histopathological classifications 
for oral SCC have been developed in order to explain 
the divergent biological behavior of tumors with appar-
ently similar clinical features. Many authors, at differ-
ent times, proposed new histological grading systems 
for tumors in an attempt to predict their clinical beha-
viour (11-14). 
Based on these data, this study aimed to test the hy-
pothesis if comparison the outcomes of similar clinical 
stages between younger patients (≤ 40 years) and older 
patients (patients ≥ 50 years), the aggressive nature of 
squamous cell carcinoma in younger individuals is due 
to a higher pathologic grade of the tumor.
Material and Methods
All patients aged under 40 years old with primary intra-
oral SCC treated at the Parana Western Union Hospital 
for Studies and Cancer Combat - Uopeccan and Cas-
cavel Oncology Center - Ceonc from 1998 to 2013 were 
retrieved. 
Inclusion criteria were records with complete clinico-
pathological and demographic data, treatment based 
on surgery with or without adjuvant radiotherapy and/
or chemotherapy and viability for analysis of tumor tis-
sue embedded in paraffin blocks. The Research Ethics 
Committee of the Piracicaba Dental School, State Uni-
versity of Campinas, Protocol 100/2012 approved this 
study.
The demographic data (age and gender), social habits 
(tobacco and alcohol consumption), tumor location, 
TNM stage, surgical margins, lymph node involvement, 
recurrence, metastasis, treatment and the patient’s cur-
rent status were obtained from medical records. The 
results were compared with a control group (age ≥ 50 
years) selected in a paired form of treated patients files 
in the period in the same institutions and with similar 
clinicopathological features (Tables 1,2).
- Histopathological analysis 
After the sample selection, new histological sections 
with 4 µm thick were obtained from the paraffin blocks 
corresponding to surgical specimens and stained with 
hematoxylin and eosin (HE). The slides were evalu-
ated using an optical microscope according to four his-
topathologic grading systems: 1) World Health Organi-
zation System - WHO System, 2) Malignancy Invasive 
Margins Deep Grading System - MG system (12), 3) 
Histological Risk Model - HR System (13) and 4) BD 
Risk Score (14).
Scoring was carried out simultaneously by two cali-
brated authors (ISC and ALCAR) until consensus was 
achieved. To determine the intra-observer degree of 
agreement, 30% (n = 34) of the samples were randomly 
selected and examined twice. The intra-observer Co-
hen’s kappa coefficients were 0.83 for WHO grading 
system, 0.86 for MG system, 0.84 for HR model, and 
0.88 for BD model. All investigators were blinded to 
demographic and clinical data and outcomes.
- Statistical analysis
The associations between the categories of demograph-
ic and clinical data, as well as diagnostic of histopatho-
logical grading systems of the tumors were performed 
using the Chi-square test for independence and Fisher 
exact test. The age data was evaluated for standard dis-
tribution using the Shapiro-Wilk normality test and ho-
mogeneity of variance by F test. As these assumptions 
were not accepted, the two age groups were compared 
using the nonparametric Mann-Whitney. The analysis 
of overall survival and disease-free survival were per-
formed according to the Kaplan-Meier method, com-
paring the two age classes through the Gehan’s Wil-
coxon test. The significance level was 0.05. Analyses 
were performed in the statistical package Statistica 7.0 
(Statsoft, 2004).
Results
During the studied period, were identified 22 patients 
aged under 40 years with oral SCC in the institutions 
surveyed. Of these 22 patients, 14 (63.64%) met the in-
clusion criteria. The mean age of these 14 patients was 
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36.21 years (± 3.89), ranging from 20 to 40 years. Most 
patients were male 12 (85.71%) and 2 (14.29%) were fe-
male. Regarding the social habits, 10 (71.43%) reported 
smoking and 7 (50%) alcohol consumption. The mean 
age of the control group patients was 63.14 years (± 
8.62), ranging from 50 to 84 years. Most were male 11 
(78.57%) and 3 (21.43%) were female. According to the 
habits, 8 (57.14%) reported tobacco and 6 (42.87%) al-
cohol consumption. Regarding the tumor location, 11 
(78.57%) developed on the tongue and 3 (21.43%) on 
the floor of mouth in the group of young patients. In 
the control group, 9 (64.29%) occurred on the tongue, 4 
(28.57%) on the floor of mouth and 1 (7.14%) on the pal-
ate. The comparison between groups of young patients 
and control patients showed no significant differences 
regarding gender (p = 0.622), smoking habit (p = 0.543), 
alcohol consumption (p = 0.871) and tumor location (p 
= 0.511) (Table 1).
In both groups, young and control, 10 patients (71.42%) 
were classified as early stages T1-T2 and 4 (28.58%) as 
advanced stage T3-T4. Regarding the stage N, 10 pa-
tients (71.73%) in each group had non-metastatic re-
VARIABLES <40 YEARS >50 YEARS p  N % N % 
AGE*       
VARIATION 20 – 40 
36,21b±3,89 
50 – 84 
63,14a±8,62 
< 
0.0001 MEAN+DP 
GENDER**      
MALE 12 85,71 11 78,57 0.622 FEMALE 2 14,28 3 21,43 
TOBACCO CONSUMPTION**      
YES 10 71,43 8 57,14 
0.543 NO 3 21,43 3 21,43 
NOT AVAILABLE 1 7,14 3 21,43 
ALCOHOL CONSUMPTION**      
YES 7 50,00 6 42,87 
0.871 NO 5 35,71 5 35,71 
NOT AVAILABLE 2 14,29 3 21,43 
LOCATION**      
TONGUE 11 78,57 9 64,29 
0.511 FLOOR OF MOUTH 3 21,43 4 28,57 
PALATE 0 0 1 7,14 
 
Table 1. Distribution of patients according to age, gender, habits and location of the tumor.
* Mann-Whitney-U Test ** Chi Square Test for independence *** different letter express statis-
tical differences between the analyzed categories.
VARIABLES <40 YEARS >50 YEARS P  N % N % 
T STAGE**      
T1 8 57,14 8 57,14 
1.000 T2 2 14,29 2 14,29 T3 2 14,29 2 14,29 
T4 2 14,29 2 14,29 
N STAGE**      
N0 10 71,43 10 71,43 
0.766 N1 2 14,29 3 21,43 
N2 2 14,29 1 7,14 
M STAGE**      
M0 14 100 14 100 1.000 
STAGING**      
STAGE I 8 57,14 8 57,14 
0.924 STAGE II 1 7,14 1 7,14 STAGE III 1 7,14 2 14,29 
STAGE IV 4 28,57 3 21,43 
 
Table 2. Distribution of patients according to clinical staging.
* Mann-Whitney-U Test ** Chi Square Test for independence.
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gional lymph nodes (N0). In the youth group, 2 patients 
(14.29%) were N1 and 2 (14.29%) were N2. In the con-
trol group, 3 patients (21.43%) were N1 and 1 patient 
(7.14%) was N2. For distant metastasis, in both groups 
all 14 patients (100%) were M0. Clinical staging in both 
groups showed that 9 patients (64.28%) were classified 
as stage I and II, and 5 patients (35.72%) as stages III 
and IV. The comparison between groups of young pa-
tients and control patients showed no difference in the 
T stage (p = 1.000), N stage (p = 0.766), M stage (p = 
1.000) and clinical stage (p = 0.924) (Table 2).
As for treatment performed in young patients, 4 (28.57%) 
underwent only surgery, 4 (28.57%) surgery associated 
with radiotherapy and 6 (42.86%) surgery associated 
with radiotherapy and chemotherapy. In control patients 
group, 7 (50%) were surgery and other 7 (50%) surgery 
associated with radiotherapy (Table 3).
The analysis of surgical margins showed that in 11 
young patients (78.57%) the surgical margins were free 
and in 2 (14.29%) compromised. In one patient (7.14%) 
this information was not available. In all 14 control pa-
tients (100%) the surgical margins were free (Table 3). 
Neck dissection was performed in 10 (71.42%) young 
patients and in 7 (50%) control patients. Histopathologi-
cal confirmation of lymph node commitment was ob-
served in 2 patients (14.29%) in each group (Table 3).
In the clinical follow-up after cancer treatment, 8 young 
patients (57.14%) presented recurrence/metastasis com-
pared to only 2 control patients (14.29%). Of the young 
patients with recurrence/metastasis, in 2 (25%) was lo-
cal, in 2 (25%) was in lymph node and in 4 (50%) was 
local and in lymph node. In the control group, 1 patient 
(7.14%) had local recurrence and 1 (7.14%) in lymph 
node (Table 3). Comparing both groups, young patients 
had almost 4 times more risk to develop recurrence/
metastasis than the control group (OR=3.998). As for 
VARIABLES <40 YEARS >50 YEARS 
p 
    N % N   % 
TREATMENT**      
SURGERY 4 28,57 7 50,00 
0.022 SURGERY + RT 4 28,57 7 50,00 
SURGERY + RT + CT 6a 42,86 0b 0 
SURGICAL MARGINS**      
FREE 11 78,57 14 100 
0.186 COMPROMISED 2 14,29 0 0 
NOT AVAILABLE 1 7,14 0 0 
LYMPH NODE INVOLVEMENT**      
YES 2 14,29 2 14,29 
0.254 NO 9 64,28 5 35,71 
NOT AVAILABLE 3 21,43 7 50,00 
RECURRENCE/ METASTASIS**      
NO 6 42,86 12 85,71 
0.018 
YES 8a 57,14 2b 14,29 
Local 2 25,00 1 7,14  
Lymph node 2 25,00 1 7,14 0.435 
Local + lymph node 4 50,00 0 0  
CURRENT STATUS**      
ALIVE 7 50,00 7 50,00 
1.000 
DEAD 7 50,00 7 50,00 
 
Table 3. Patients’ distribution according to treatment and follow up. 
* Mann-Whitney-U Test ** Chi Square Test for independence *** different letter express statistical 
differences between the analyzed categories.
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the current status of the patients, 7 (50%) in each group 
were alive and 7 (50%) dead. Of the dead patients, 5 
(71.43%) in each group died due to tumor (Table 3).
The comparison between young and control groups 
showed a greater association of treatment modalities 
used in younger patients (p = 0.022) and younger patients 
had higher rate of recurrence/metastasis (p = 0.018). On 
the other hand, regarding the surgical margins, lymph 
node commitment and current status did not differ be-
tween the groups, with p values respectively (p = 0.186) 
(p = 0.254) and (p = 1.000) (Table 3).
The overall survival rate (OS) in 5 and 10 years in the 
young group was 64% and 48%, respectively. In the 
control group, the overall survival rate (OS) in 5 and 
10 years was 78% and 19%, respectively.  Disease-free 
survival rate (DFS) for young patients was 37% in 5 
years and 10 years. For the control patients the DFS was 
78% in 5 years and 18% in 10 years. Comparing the two 
groups through Gehan’s Wilcoxon test, it was observed 
tendency to statistical difference in 5 years DFS (p = 
0.069), where young patients had worse rate (Fig. 1). 
There was no significant difference in overall survival 
rate between the groups (p = 0.376). 
The WHO grading system classified in both groups, 
young and control patients, 13 tumors (92.85%) as well 
or moderately differentiated and 1 (7.15%)  as poorly 
differentiated. No significant associations were ob-
served between the studied groups in the WHO grading 
system (Table 4 and 4 continue).
The MG grading system ranked all 14 tumors of young 
and control patients as low or intermediate risk. In the 
young patients 1 tumor was classified as low risk and 
13 (92.86%) as intermediate risk. In the control group 3 
tumors were classified as low risk and 11 as intermedi-
ate risk. There were no significant associations with this 
classification in the comparative analysis between the 
groups (Table 5 and 5 continue).
In HR grading system, 7 tumors (50%) in the young 
group were classified as low or intermediate risk and 
7 (50%) as high risk. In the control group 6 tumors 
(42.86%) were classified as low or intermediate risk and 
8 (57.14) as high risk. When evaluating the relationship 
between the young and control groups, there were sta-
tistical differences in the variables clinical stage III/IV 
(p = 0.002), free surgical margins (p = 0.002) and ab-
sence of regional recurrence (p = 0.017) (Table 6 and 6 
continue).
The BD risk score was performed in 13 young patients 
and in 6 was classified as low or intermediate risk and 
in 7 as high risk. In the control group 8 tumors as low 
or intermediate risk and in 6 as high risk. No significant 
correlation was observed between clinical parameters 
and the BD risk score in the comparison between groups 
(Table 7 and 7 continue). Analyzing the results of the 
four grading system, it was noted that more tumors in 
both group ages were classified as poor differentiated or 
high risk in the HR and BD system comparing to WHO 
and MG systems (Table 8).
 
Discussion 
In Brazil, oral carcinoma is among the 10 most inci-
dents cancers and it is estimated approximately 15,000 
new cases for the year 2014. Among young patients, the 
incidence is considered low and retrospective analyzes 
 
Fig. 1. Comparative analysis of disease free survival rate among groups.
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 WHO grading system 
  ≤ 40 years ≥ 50 years p  
  n (%) n (%)  
Gender     
     Male W/M  11 (91,67) 10 (90,91) 0.949  P 1 (8,33) 1 (9,09) 
     Female W/M  2 (100) 3 (100) 1  P  0 0 
Tobacco consumption     
      No W/M 3 (100) 3 (100) 1  P 0 0 
      Yes W/M 9 (90) 7 (87,50) 0.867  P  1 (10) 1 (12,50) 
Alcohol consumption     
      No W/M  5 (100) 5 (100) 1  P  0 0 
      Yes W/M  6 (85,71) 6 (100) 0.335  P  1 (14,29) 0 
Location     
      Tongue W/M  10 (90,91) 9 (100) 0.353  P  1 (9,09) 0 
      Floor of mouth  W/M  3 (100)  3 (75) 0.350  P 0 1 (25) 
      Palate W/M 0 1 (100) 1  P 0 0 
Stage T      
      T1/T2 W/M  10 (100) 9 (90) 0.305  P 0 1 (10) 
      T3/T4 W/M  3 (75) 4 (100)      0.285  P 1 (25) 0 
Stage N      
      N0 W/M  10 (100) 9 (90) 0.305  P 0 1 (10) 
      N+ W/M  3 (75) 4 (100) 0.285  P 1 (25) 0 
Clinical stage     
       I / II W/M  9 (100) 8 (88,89) 0.303  P  0 1 (11,11) 
       III/IV W/M 4 (80) 5 (100) 0.292 
  P 1 (20) 0 
Treatment     
      Surgery W/M 4 (100)  7 (100) 1  P 0 0 
      Surgery +RT W/M 4 (100) 6 (85,71) 0.428  P 0 1 (14,29) 
      Surgery +RT+CT W/M 5 (83,33) 0 1  P 1 (16,67) 0 
Surgical margins     
      Free W/M 10 (90,91) 13 (92,86) 0.859  P 1 (9,09) 1 (7,14) 
      Compromised W/M 2 (100) 0 1  P 0 0 
      Not available W/M 1 (100) 0 1  P 0 0 
Recurrence     
      No W/M 6 (100) 11 (91,67) 0.467  P 0 1 (8,33) 
      Yes W/M 7 (87,50) 2 (100) 0.598  P 1 (12,50) 0 
Local recurrence      
      No W/M 8 (100) 12 (92,31) 0.421  P 0 1 (7,69) 
      Yes W/M 5 (83,33) 1 (100) 0.659  P 1 (16,67) 0 
Table 4. Association of clinical and demographic characteristics of the tumors 
of young patients (≤ 40 years) and control patients (≥ 50 years) with histopatho-
logical classification according to the WHO system.
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are rarely higher rates to 6% of this tumor in this pop-
ulation. However, in recent years, it has been seen an 
increased incidence of oral carcinoma among patients 
younger than 40 years old (5,15-17). Hirota et al. (4) in 
a retrospective study conducted in Brazil between 1994 
and 2004, observed incidence of SCC in young patients 
of 10.7%.
The prevalence of oral carcinoma is higher in male pa-
tients with variable ratios. In the study of Udeabor et 
al. (6), the ratio men:women was 3.8: 1. However, other 
studies showed lower ratios, being 1.6: 1 (4,5). In the 
current study the ratio was 6: 1, which is higher than 
other studies. There is no consensus in the literature 
about demographic characteristics, lifestyle, etiology, 
prognosis and results in young patients with oral carci-
noma. In this study, it was found that the majority of pa-
tients were male (85.71%), consumed tobacco (71.43%) 
and alcohol (50%) and often the predominant location 
of the tumors was tongue (78.57%), similar data to the 
control group.
The fact that even when young patients have the risk 
factors of tobacco and alcohol, it has shorter period of 
time to induce carcinogenesis when compared to older 
patients; allowing new research about other etiologic 
factors responsible for the development of SCC in young 
individuals, such as genetic abnormalities and viral in-
fections (4-6,8,18,19). 
Furthermore, it has been suggested that oral carcinoma 
in young individuals could be related to the possibility 
of this tumor being a different type of cancer with ap-
parently more aggressive biological behaviour (15,20). 
However, there is no consensus in the literature on this 
subject. Some studies found no significant differences 
between groups with different age groups regarding 
biological behavior of tumors (18,21). 
In this study, the majority of young patients (64.28%) 
were diagnosed at an early stage (I and II), different 
than the study Benevenuto et al. (18) in which 67% of 
oral SCC in young patients were diagnosed in stages III 
and IV. The higher proportion of young patients with 
advanced tumors can be explained by delayed diagno-
sis, as also occurs in older patients (16) or by a possible 
more aggressive tumor behavior in this group of patient 
(8).
The parameters used to plan the treatment of patients 
with SCC are mainly based on clinical staging of the 
disease. The main form of treatment of oral carcinoma 
is surgery, which is frequently combined with other 
modalities such as radiotherapy and chemotherapy 
particularly in more advanced cases (22). Montero et 
al. (10), in a systematic review, from 2007 to 2012 on 
SCC features in young patients, noted that the evaluated 
studies showed a predominance of surgery for treatment 
of young patients, followed by combination surgery + 
radiotherapy. According to the authors, the association 
of chemotherapy would be a suitable option for more 
advanced tumors, with margins showing neoplastic 
infiltration. They also noted that the treatment used to 
pump in young patients is similar to that used in older 
individuals. However, according to the analyzed stud-
ies, the young patients are often subjected to combina-
tion treatments, regardless of the stage of the disease, 
because some authors have reported that the SCC’s be-
havior is more aggressive in this group. In the current 
study, it was also observed that young patients received 
a higher association of treatment modalities than the 
control group, being the difference statistically signifi-
cant (p = 0.022). 
Affected surgical margins, according Binahmed et al. 
(23) may be associated with local recurrence and poorer 
Regional recurrence     
      No W/M 8 (100) 12 (92,31) 0.421  P 0 1 (7,69) 
      Yes W/M 5 (83,33) 1 (100) 0.659  P 1 (16,67) 0 
Distant metastasis     
     No W/M 13 (92,86) 13 (92,86) 1  P 1 (7,14) 1 (7,14) 
     Yes W/M 0 0 1  P 0 0 
Status     
    Alive W/M 7 (100) 7 (100) 1  P 0 0 
    Dead W/M 6 (85,71) 6 (85,71) 1  P 1 (14,29) 1 (14,29) 
 
 
W/M: Well/Moderately differentiated, P: Poorly differentiated, RT: Radiotherapy, 
CT: Chemotherapy
Table 4 Continue. Association of clinical and demographic characteristics of the 
tumors of young patients (≤ 40 years) and control patients (≥ 50 years) with histo-
pathological classification according to the WHO system.
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 MG grading system 
  ≤ 40 years ≥ 50 years  p  
  n (%) n (%)  
Gender      
     Male L/I  12 (100) 11 (100) 1  H 0 0 
     Female L/I  2 (100) 3 (100) 1  H  0 0 
Tobacco consumption     
      No L/I 3 (100) 3 (100) 1  H 0 0 
      Yes L/I 10 (100) 8 (100) 1  H  0 0 
Alcohol consumption     
      No L/I  5 (100) 5 (100) 1  H  0 0 
      Yes L/I  7 (100) 6 (100) 1  H  0 0 
Location     
      Tongue L/I  11 (100) 9 (100) 1  H  0 0 
      Floor of mouth  L/I  3 (100) 4 (100) 1  H 0 0 
      Palate L/I 0 1 (100) 1  H 0 0 
Stage T      
      T1/T2 L/I  10 (100) 10 (100) 1  H 0 0 
      T3/T4 L/I  4 (100) 4 (100)         1  H 0 0 
Stage N      
      N0 L/I  10 (100) 10 (100) 1  H 0 0 
      N+ L/I  4 (100) 4 (100) 1  H 0 0 
Clinical stage     
       I / II L/I  9 (100) 9 (100)  
1  H  0 0 
       III/IV L/I 5 (100) 5 (100)   
1  H 0 0 
Treatment     
      Surgery L/I 4 (100) 7 (100)  
1  H 0 0 
      Surgery +RT L/I 4 (100) 7 (100)  
1  H 0 0 
      Surgery +RT+CT L/I 6 (100)  0 1  H 0 0 
Surgical margins     
      Free L/I 11 (100) 14 (100) 1  H 0 0 
      Compromised L/I 2 (100) 0 1  H 0 0 
      Not available L/I 1 (100) 0 1  H 0 0 
Recurrence     
      No L/I 6 (100) 12 (100)  
1  H 0 0 
      Yes L/I 8 (100) 2 (100)  
1  H 0 0 
Local recurrence     
      No L/I 8 (100) 13 (100)  
1  H 0 0 
      Yes L/I 6 (100) 1 (100)  
1  H 0 0 
Table 5. Association of clinical and demographic characteristics of the young pa-
tients (≤ 40 years) and control patients (≥ 50 years) with histopathological classifica-
tion according to MG grading system.
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survival rates. On the other hand, Brandwein-Gensler et 
al. (13) in their study, found that the histological grading 
is more important that the assessment of surgical mar-
gins in determining the prognosis. In the present study, 
it was observed that only 2 young patients presented 
compromised surgical margins and all patients of the 
control group had free surgical margins, but the differ-
ence was not significant. 
One of the major clinical prognostic indicators is the 
nodal status, so that survival can decrease by 20% when 
regional metastases are present (24). In this study, neck 
dissection was performed in 10 (71.42%) young patients 
and in 7 (50%) control patients and histopathological 
confirmation of lymph node involvement was seen in 
only 2 patients of each group and the difference was not 
significant. 
Regarding recurrence and metastasis, Siriwardena et al. 
(20) observed a higher recurrence rate in young (39%) 
than in older patients (30%). In the review by Montero 
et al. (10) it was observed a controversy between ana-
lyzed studies with regard recurrence rates of oral carci-
noma in young patients. In the current study there was 
a higher rate of local recurrence and regional metastasis 
among young people and the difference was statistically 
significant (p = 0.018). 
An important feature of causal effects of age on sur-
vival are the comorbidities in other systems, which are 
more common in older patients and demonstrate a sig-
nificant impact on the prognosis (25). In addition, over-
all survival rates seem to be more favorable in patients 
with no history of risk factors compared to those who 
use tobacco and alcohol, regardless of age (10). That is, 
a longer period associated with these diseases could 
lead to reduced patient survival. The study of Monsjou 
et al. (1) also found that younger patients had better OS 
rate, possibly due to the influence of comorbidities as-
sociated with old age. On the other hand, no significant 
difference in DFS rates among the young and elderly 
patients was noted. In the current study it was observed 
that young patients had DFS rate in 5 years significantly 
lower (37.68%) than the control group (77.78%), sug-
gesting greater aggressiveness of tumors in the first 
group. However, in 10 years, this rate has remained in 
the young group and decreased in the control (18.84%). 
Regarding the OS rate, the difference between groups 
in 5 and 10 years was not significant.
The evaluation of prognostic factors of oral SCC has 
been widely studied in order to achieve more effective 
therapeutic strategies. Considering the poor prognosis 
of oral SCCs, as well as clinical studies, several his-
topathological grading systems have been developed 
trying to explain the differences in biological behavior 
of tumors with similar clinical characteristics (9). How-
ever, none of these systems is universally accepted (26). 
The current study used the systems developed by WHO, 
Bryne et al. (12), Brandwein-Gensler et al. (13) and Al-
mangush et al. (14).
Regarding the histopathological grading of tumors, sev-
eral authors found a similarity between groups of young 
and elderly patients (6,15,17,18). On the contrary, Kami-
nagakura et al. (21) found a higher frequency of poorly 
differentiated tumors in young patients compared to 
older.
Although the WHO system for histopathological clas-
sification of SCC is largely employed, their use as prog-
nostic tool has been criticized. The main criticism of 
this system refers to their subjectivity, in the absence 
of important features related to tumorigenesis, such as 
pattern of invasion and, more importantly, the poor cor-
relation with the results and responses to treatment (12). 
Table 5 Continue. Association of clinical and demographic characteristics of the 
young patients (≤ 40 years) and control patients (≥ 50 years) with histopathological 
classification according to MG grading system.
Regional Recurrence      
      No L/I 8 (100) 13 (100)  
1  H 0 0 
      Yes L/I 6 (100) 1 (100)  
1  H 0 0 
Distant metastasis     
     No L/I 14 (100) 14 (100)  
1  H 0 0 
     Yes L/I 0 0  
1  H 0 0 
Status     
    Alive L/I 7 (100) 7 (100) 1  H 0 0 
    Dead L/I 7 (100) 7 (100)   
1  H 0 0 
 
 
L/I: Low/Intermediate risk, H: High risk, RT: Radiotherapy, CT: Chemotherapy.
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 HR grading system 
  ≤ 40 years ≥ 50 years p  
  n (%) n (%)  
Gender      
   Male L/I  6 (50) 3 (27,27) 0.265  H 6 (50) 8 (72,73) 
     Female L/I  1 (50) 3 (100) 0.171  H  1 (50) 0 
Tobacco consumption     
      No L/I 3 (100) 3 (100) 1  H 0 0 
      Yes L/I 3 (30) 2 (25) 0.814  H  7 (70) 6 (75) 
Alcohol consumption     
      No L/I  4 (80) 4 (80) 1  H  1 (20) 1 (20) 
      Yes L/I  1 (14,29) 2 (33,33) 0.416  H  6 (85,71) 4 (66,67) 
Location     
      Tongue L/I  5 (45,45) 4 (44,44) 0.964  H  6 (54,55) 5 (55,56) 
      Floor of mouth  L/I  2 (66,67) 4 (100) 0.212  H 1 (33,33) 0 
      Palate L/I 0 1 (100) 1  H 0 0 
Stage T      
      T1/T2 L/I  6 (60) 5 (50) 0.653  H 4 (40) 5 (50) 
      T3/T4 L/I  1 (25) 1 (25) 1  H 3 (75) 3 (75) 
Stage N      
      N0 L/I  6 (60) 6 (60) 1  H 4 (40) 4 (40) 
      N+ L/I  1 (25) 0 0.285  H 3 (75) 4 (100) 
Clinical stage     
       I / II L/I  9 (100) 6 (66,67)  
0.058  H  0 3 (33,33) 
       III/IV L/I 5 (100) 0  
0.002  H 0 5 (100) 
Treatment     
      Surgery L/I 3 (75) 7 (100)  
0.165  H 1 (25) 0 
      Surgery +RT L/I 2 (50) 6 (85,71)  
0.201  H 2 (50) 1 (14,29) 
      Surgery +RT+CT L/I 2 (33,33) 0  
1  H 4 (66,67) 0 
Surgical margins     
      Free L/I 11 (100) 6 (42,86)  
0.002  H 0 8 (57,14) 
      Compromised L/I 2 (100) 0  
1  H 0 0 
      Not available L/I 0 0  
1  H 1 (100) 0 
Recurrence     
      No L/I 3 (50) 6 (50)  
1  H 3 (50) 6 (50) 
      Yes L/I 4 (50) 0  
0.197  H 4 (50) 2 (100) 
Local recurrence     
      No L/I 4 (50) 6 (46,15)  
0.864  H 4 (50) 7 (53,85) 
      Yes L/I 3 (50) 1 (100)  
0.350  H 3 (50) 0 
Table 6. Association of clinical and demographic characteristics of the tumors 
of young patients (≤ 40 years) and control patients (≥ 50 years) with histopatho-
logical classification according to the HR grading system.
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In the current study the WHO grading system in both 
groups ranked 13 tumors (92.85%) as well or moderate-
ly differentiated and 1 (7.15%) as poorly differentiated 
and the difference between them was not statistically 
significant. 
Since it was described as an applicable grading system 
in biopsies, the MG system (12) has been used for prog-
nostic analysis, but the results of the studies are contro-
versial (9,24) which can be explained by the subjectiv-
ity attributed to some of their parameters resulting in 
high variability among examiners (27). In this study, 
the majority of tumors in both groups were classified 
as intermediate risk and again no difference was found 
between the groups.
The HR system (13) was proposed as a multiparameter 
system modified and updated with an important role 
in making decisions about the need for post-operative 
therapy and prognosis of patients with oral carcinoma. 
Although some studies, such as and Lindenblatt et al. 
(9) have confirmed their predictive value, other, more 
recently, such as Almangush et al. (14) and Rodrigues 
et al. (26) showed no correlation between this system 
and the epidemiological and clinical characteristics. 
According to Rodrigues et al. (26) none of the three pa-
rameters individually considered in the HR system as 
prognostic predictors has shown high reproducibility. 
In the current study, the HR grading system ranked 7 
tumors of the youth group as low or intermediate risk 
and 7 as high prognostic risk. In the control group 6 
tumor was classified as low or intermediate risk and 8 as 
high prognostic risk. It was observed statistical differ-
ences between the young and control groups regarding 
clinical stages III / IV, free margins and the absence of 
regional recurrence. 
The BD risk score (14) is the latest proposal for his-
topathologic grading system of oral cancers. It’s two 
evaluation items, the depth of tumor invasion and tu-
mor cell nests have been individually described as prog-
nostic predictors for patients with oral carcinoma. The 
importance of these factors also have been highlighted 
in other studies. In the current study, there was no dif-
ference between the group of young patients and the 
control group patients compared to histological grading 
system for BD. Interestingly, in the HR and BD systems 
more tumors were classified as high risk prognosis than 
in the WHO and MG systems, suggesting that these 
systems can more accurately identify undifferentiated 
tumors than WHO and MG systems. 
In summary, this study showed that no differences were 
observed in the histological grading in four used sys-
tems (WHO, MG, HR and BD) between young and con-
trol patients with tumors of similar location and clini-
cal stage. However, even considering the limitation of 
the sample, it was noticed that younger patients had a 
higher rate of local recurrence, high rate of regional me-
tastases and lower 5-year disease-free survival, despite 
of similar clinicopathological features and use of more 
therapeutic modalities.
Table 6 Continue. Association of clinical and demographic characteristics of 
the tumors of young patients (≤ 40 years) and control patients (≥ 50 years) with 
histopathological classification according to the HR grading system.
Regional recurrence      
      No L/I 5 (62,50) 13 (100)  
0.017  H 3 (37,50) 0 
      Yes L/I 2 (33,33) 1 (100)  
0.212  H 4 (66,67) 0 
Distant metastasis     
     No L/I 7 (50) 6 (42,86)  
0.705  H 7 (50) 8 (57,14) 
     Yes L/I 0 0  
1  H 0 0 
Status     
    Alive L/I 4 (57,14) 4 (57,14)  
1  H 3 (42,86) 3 (42,86) 
    Dead L/I 3 (42,86) 2 (28,57) 0.577  H 4 (57,14) 5 (71,43) 
 
 
L/I: Low/Intermediate risk, H: High risk, RT: Radiotherapy, CT: Chemo-
therapy.
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 BD risk score  
  ≤ 40 years ≥ 50 years p  
  n (%) n (%)  
Gender      
     Male L/I  5 (45,45) 6 (54,55) 0.670  H 6 (54,55) 5 (45,45) 
     Female L/I  1 (50) 2 (66,67) 0.710  H  1 (50) 1 (33,33) 
Tobacco consumption     
      No L/I 2 (66,67) 2 (66,67) 1  H 1 (33,33) 1 (33,33) 
      Yes L/I 3 (33,33) 5 (62,50) 0.229  H  6 (66,67) 3 (37,50) 
Alcohol consumption     
      No L/I  3 (60) 3 (60) 1  H  2 (40) 2 (40) 
      Yes L/I  2 (33,33) 4 (66,67) 0.248  H  4 (66,67) 2 (33,33) 
Location     
      Tongue L/I  5 (50) 6 (66,67) 0.462  H  5 (50) 3 (33,33) 
      Floor of mouth L/I  1 (33,33) 1 (25) 0.180  H 2 (66,67) 3 (75) 
      Palate L/I 0 1 (100) 1  H 0 0 
Stage T      
      T1/T2 L/I  5 (50) 5 (50) 1  H 5 (50) 5 (50) 
      T3/T4 L/I  1 (33,33) 3 (75) 0.270  H 2 (66,67) 1 (25) 
Stage N      
      N0 L/I  5 (50) 6 (60) 0.653  H 5 (50) 4 (40) 
      N+ L/I  1 (33,33) 2 (50) 0.659  H 2 (66,67) 2 (50) 
Clinical stage      
       I / II L/I  5 (55,56) 5 (55,56)  
1  H  4 (44,44) 4 (44,44) 
       III/IV L/I 1 (25) 3 (60)  
0.294  H 3 (75) 2 (40) 
Treatment     
      Surgery L/I 3 (75) 4 (57,14)  
0.554  H 1 (25) 3 (42,86) 
      Surgery +RT L/I 2 (50) 4 (57,14)  
0.819  H 2 (50) 3 (42,86) 
      Surgery +RT+CT L/I 1 (20) 0  
1  H 4 (80) 0 
Surgical margins     
      Free LB/I 5 (50) 8 (57,14)  
0.729  H 5 (50) 6 (42,86) 
      Compromised L/I 0 0  
1  H 2 (100) 0 
      Not available L/I 1 (100) 0  
1  H 0 0 
Recurrence     
      No L/I 4 (66,67) 7 (58,33)  
0.732  H 2 (33,33) 5 (41,67) 
      Yes L/I 2 (28,57) 1 (50)  
0.571  H 5 (71,43) 1 (50) 
Local recurrence     
      No L/I 4 (50) 8 (61,54)  
0.604  H 4 (50) 5 (38,46) 
      Yes L/I 2 (40) 1 (100)  
0.273  H 3 (60) 0 
Table 7. Association of clinical and demographic characteristics of the tumors 
of young patients (≤ 40 years) and control patients (≥ 50 years) with histopatho-
logical classification according to the BD risk score.
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